FDA REFORM PROVISION MANDATING STRICT ADHERENCE TO 180-DAY PMA REVIEW TIME FRAME WILL LEAD TO MORE RIGOROUS FILING REVIEWS -- ODE's RICHTER
This article was originally published in The Gray Sheet
Executive Summary
FDA likely will raise the standard for premarket approval application filing decisions as a result of the provision in pending FDA reform legislation ordering the agency adhere to the statutory 180-day PMA review time frame, Kimber Richter, Deputy Director for Clinical and Review Policy in FDA's Office of Device Evaluation, indicated at the Oct. 21 Association of Medical Diagnostics Manufacturers annual meeting in Rockville, Maryland.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.